Lung cancer (non small cell, EGFR-TK mutation positive) - erlotinib (1st line): appendix a - provisional matrix of stakeholders

Lung cancer (non small cell, EGFR-TK mutation positive) - erlotinib (1st line): appendix a - provisional matrix of stakeholders

Lung cancer (non small cell, EGFR-TK mutation positive) - erlotinib (1st line): appendix a - provisional matrix of stakeholders
13 October 2014
(100.37 Kb 29 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 10 October 2014